Board of Directors
Larry Pentz - Chairman - BS ChE MBA*
Larry Pentz was appointed to the Board in 2008 and became Chairman in 2014. Larry has over 30 years' service within multi-national corporations in a variety of operational and general management positions. He has extensive experience in developing strategy for and successfully leading international growth businesses. Larry has been instrumental in the acquisition and integration of multiple catalyst and chemical companies for Johnson Matthey Plc, and was formerly executive director responsible for Emission Control Technologies of Johnson Matthey Plc.
Larry recently retired as an Executive director of Johnson Matthey Plc where he held board level responsibility for Johnson Matthey’s Process Technologies and Fine Chemicals Divisions. Larry is Non-Executive Chairman-Designate of the Board of Directors of Scapa Group plc and will be appointed Non-Executive Chairman with effect from 31 March 2017.
David Hummel - Chief Executive - BSc
David Hummel assumed responsibility for VICTREX PEEK worldwide in 1992 and has more than 25 years of experience of the global high performance polymer industry. Formerly with Diamond Shamrock, GE Plastics and ICI, David was appointed to the Board in 1993 following his leading of the successful MBO of Victrex from ICI. He has served as CEO of Victrex since that time, overseeing strategic decision making and day to day management and leadership of the business.
Louisa Burdett - Group Finance Director BSc Hons, ACA
Louisa Burdett was appointed as Group Finance Director in February 2014. Louisa formerly held the position of Chief Financial Officer at Optos plc. Prior to this, Louisa was Chief Financial Officer at the Financial Times Group from 2008 to 2012. Louisa has also held roles at Chep Europe, a division of Brambles Ltd, the Australian listed pallet distribution company, GE Healthcare and GlaxoSmithKline plc. Louisa has also worked as an M&A Consultant at Charterhouse Bank and spent four years at KPMG in London.
Louisa is Chairman of the Currency Committee.
Tim Cooper - Executive Director - BA Hons
Tim Cooper was appointed as an executive director to the Board in October 2012. Tim joined Victrex in January 2010 as Managing Director of Victrex Polymer Solutions. Tim has over 30 years of international business management and commercial experience, having held senior leadership positions in a number of industries. Prior to joining the Victrex business, Tim was with Umeco Plc, initially as Managing Director of Aerovac Systems Ltd, but later becoming Group Managing Director of Umeco Composites Process Materials. He has been Managing Director of Tellermate Plc and of Avery Berkel Ltd, having developed his international career with GEC, BP and Land Rover.
Martin Court - Executive Director - BSc (Eng), PhD
Martin was appointed to the Board as an executive director in April 2015. Martin joined Victrex in February 2013 as Managing Director of Invibio, Victrex's medical business. Martin has significant proven international experience in the medical and high performance materials & chemicals industries, including with Cytec Industries, and in a number of senior roles at both ICI and UCB. He is an INSEAD alumni, holds a doctorate in the field of surface chemistry and fracture mechanics and a BSc (Eng) degree in mineral technology from Imperial College of Science and Technology.
Pamela Kirby - Non-executive Director - BSc PhD*+#
Pamela Kirby was appointed to the Board in 2011 and Senior Independent Director in 2014. Pamela has detailed knowledge of the international pharmaceutical industry, and was formerly CEO of Quintiles Transnational Corp based in North Carolina USA. Pamela has also held a number of other senior positions in the international pharmaceutical industry including AstraZeneca PLC where she was a regional director and F.Hoffmann-La Roche Ltd. where she was director of strategic marketing and business development. She was previously non-executive chairman of Oxford Immunotec Limited and non-executive director of Novo Nordisk A/S, and Smith & Nephew plc.
Pamela is a non-executive director of DCC plc, Hikma Pharmaceuticals plc, Reckitt Benckiser Group plc and Kings Health Partnership and is appointed to the supervisory board of Akzo Nobel.
Andrew Dougal - Non-executive Director - B ACC, CA*+#
Andrew Dougal was appointed to the Board in March 2015. Andrew is Chairman of the Audit Committee. Andrew is a chartered accountant and brings a wealth of experience to the Board, from a lengthy executive and non-executive career of over 35 years in industrial, manufacturing and services companies.
Andrew is a non-executive director and Chair of the Audit Committee at Carillion plc. He was previously a Non Executive Director and Audit Committee Chair of Taylor Woodrow Plc, Taylor Wimpey Plc and Creston Plc and a Non Executive Director of BPB Plc and Premier Farnell plc. Formerly, Andrew served as Chief Executive of Hanson plc., the international building materials group, following its demerger from Hanson, the Anglo- American conglomerate, where he was Finance Director and previously held a number of senior roles in general management and finance. He is a member of the Council of the Institute of Chartered Accountants of Scotland (ICAS).
Patrick De Smedt - Non-executive Director - BSc MSc*+#
Patrick De Smedt was appointed in 2008. Between 1983 and 2006, Patrick held a number of senior positions in Microsoft, during which time he founded the Benelux subsidiaries, lead the development of the Western European business and in the period 2003 and 2006 served as Chairman of Microsoft for Europe, Middle East and Africa. Patrick has previously worked with early stage ventures as well as large, established multi-nationals. He has a deep knowledge of international markets, technology and diverse industry sectors.
Patrick is Senior Independent Director at PageGroup plc, KCOM Group plc and Morgan Sindall Group plc, where he is also Chairman of the Remuneration Committee. He is a non-executive Director of Kodak Alaris Holdings Limited and Nexinto Holding Ltd.
Jane Toogood - Non-executive Director MA Hons*+#
Jane Toogood was appointed to the Board in September 2015. Jane has a wealth of experience across a number of senior marketing, sales and business development roles within the global chemical industry, including Borealis, ICI and Uniqema and held a Non-Executive Director role with NHS Harrogate and District Foundation Trust.
Jane is Divisional Director, Precious Metal Products at Johnson Matthey Plc.
- Nominations Committee
- Audit Committee
- Remuneration Committee